So, given the effect of IL-22 between its dual protective and pathogenic roles in human liver diseases, future studies should be focused on the differential roles of IL-22 and IL17 in promoting liver inflammation and fibrosis at various stages of HCV-OLT. This evidence concerns the gene IL22 and liver disorder.